What can AI do in Biology? A Briefing for the Health Community

This briefing will examine how artificial intelligence is transforming biology and the life sciences.

Topics include:

  • Drug discovery
  • Disease surveillance and pandemic preparedness
  • Biological molecule design
  • Genomic-data interpretation
  • Laboratory automation
  • How advanced AI capabilities may lower barriers for malicious biological harm and outpace existing health-security frameworks

The event will bring evidence on AI-enabled biological risks to the global health community and facilitate dialogue on preparedness and international coordination.

The agenda includes:

  • Eleanor Marshall of SecureBio on the AI-biology risk landscape
  • Justin Taylor of Anthropic on how advanced AI companies see biological risk
  • Moritz Hanke of Johns Hopkins on the governance perspective